SU764679A1 - Method of obtaining lysozyme solutions - Google Patents
Method of obtaining lysozyme solutions Download PDFInfo
- Publication number
- SU764679A1 SU764679A1 SU772553066A SU2553066A SU764679A1 SU 764679 A1 SU764679 A1 SU 764679A1 SU 772553066 A SU772553066 A SU 772553066A SU 2553066 A SU2553066 A SU 2553066A SU 764679 A1 SU764679 A1 SU 764679A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- solution
- obtaining
- lysozyme
- pulsating
- activity
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
Изобретение относится к химикофармацевтической промышленности.The invention relates to the pharmaceutical industry.
Известен способ получения раствора лизоцима путем растворения сухого $ препата в изотонйческом растворе хлорида натрия или в растворе новокаина £1] .A known method of obtaining a solution of lysozyme by dissolving dry $ preparation in an isotonic sodium chloride solution or in a solution of novocaine £ 1].
Однако известный способ не обеспечивает высокой бактериологической активности.However, the known method does not provide high bacteriological activity.
Цель изобретения - повышение активности целевого продукта.The purpose of the invention is to increase the activity of the target product.
Поставленная цель достигается тем, что раствор лизоцима, полученный из- 15 вестньйа образом, обрабатывают'пульсирующим м&гнитным полем напряженностью 1800ί 800 Э в течение 100t 3.0 мин.This goal is achieved by the fact that the lysozyme solution obtained in a well-known manner is treated with a pulsating magnetic field of intensity 1800–800 Oe for 100t 3.0 min.
Способ поясняется следующим примером.The method is illustrated by the following example.
Пример. Содержимое флакона сухого лизоцима (150 мг) растворяют в 2-3 мп изотонического раствора хлорида натрия или в 0,25% растворе новокаина. Затем раствор обрабатывают пульсирующим магнитным полем напряженностью 1800 Э в течение 100 мин.Example. The contents of a bottle of dry lysozyme (150 mg) are dissolved in 2-3 mp isotonic sodium chloride solution or in 0.25% novocaine solution. Then the solution is treated with a pulsating magnetic field with a voltage of 1800 Oe for 100 minutes.
Сравнительные данные о бактериолитической активности полученного раствора лизоцима с известным представлены в таблице.Comparative data on the bacteriolytic activity of the obtained lysozyme solution with the known are presented in the table.
Использование изобретения позволяет на порядок повысить бактериолитическую активность раствора лизоцима и эффективность лечения инфекционных заболеваний и уменьшить количество лечебных доз лизоцима.The use of the invention allows to increase by an order of magnitude the bacteriolytic activity of the lysozyme solution and the effectiveness of the treatment of infectious diseases and reduce the number of therapeutic doses of lysozyme.
С обработкой пульсирующимWith pulsating treatment
МП с напряженностьюMP with tension
1800 Э ’ 345 100 100 100 100 100 75 01800 E ’345 100 100 100 100 100 75 0
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU772553066A SU764679A1 (en) | 1977-12-08 | 1977-12-08 | Method of obtaining lysozyme solutions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU772553066A SU764679A1 (en) | 1977-12-08 | 1977-12-08 | Method of obtaining lysozyme solutions |
Publications (1)
Publication Number | Publication Date |
---|---|
SU764679A1 true SU764679A1 (en) | 1980-09-23 |
Family
ID=20737200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU772553066A SU764679A1 (en) | 1977-12-08 | 1977-12-08 | Method of obtaining lysozyme solutions |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU764679A1 (en) |
-
1977
- 1977-12-08 SU SU772553066A patent/SU764679A1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS56135418A (en) | Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human | |
DE3672868D1 (en) | TREATMENT OF SOLID PHASED BIOLOGICAL AND PHARMACEUTICAL PRODUCTS WITH VIRUSES AND PYROGENS INACTIVATING AGENTS. | |
DE68917219T2 (en) | Therapeutic product for the treatment of symptoms during or after the menopause. | |
RU93004764A (en) | AMIDA SULFAMIDO-AND SULFAMIDOKARBONYLPYRIDIN-2-CARBIC ACIDS, THEIR Pyridine-N-OXIDES, METHOD OF THEIR RECEIVING AND THEIR APPLICATION AS MEDICINE PREPARATIONS | |
FI832355A0 (en) | 9- (2-HYDROXYETOXIMETYL) guanidine derivate | |
EA199800690A1 (en) | SUBSTITUTED N - [(AMINOIMINOMETHYL) PHENYLALKYL] AZHGETHROCYLAMIDE OF SULPHONIC ACIDS | |
ATE145136T1 (en) | USE OF KETOCONAZOLE AND A RETINOID FOR THE TREATMENT OF ACNE VULGARIS | |
ES482097A1 (en) | Novel acyl-derivatives of carnitine and process for their preparation | |
DE58901002D1 (en) | AGENT WITH DESTROYING EFFECT ON MALIGNE TUMORS, METHOD FOR THE PRODUCTION THEREOF AND PREPARATION FOR USE IN THE THERAPY OF CANCER DISEASES. | |
ES8607916A1 (en) | Biscarboxamides for treating diseases, and process for their preparation. | |
SU764679A1 (en) | Method of obtaining lysozyme solutions | |
FR2659956B1 (en) | PROCESS FOR TREATING AN AQUEOUS SOLUTION CONTAINING MAINLY NITRIC ACID AND FLUORHYDRIC ACID. | |
EA199800526A1 (en) | DERIVATIVES OF BENZIMIDAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF VIRAL INFECTIONS | |
ATE27157T1 (en) | CYCLOALKYL DERIVATIVES OF BENZISOSELENAZOLONES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
ATE109006T1 (en) | PHARMACEUTICAL COMPOSITION INTENDED TO TREAT OR PREVENT RETROVIRAL INFECTIONS. | |
AU608545B2 (en) | An improved method | |
DE3275060D1 (en) | Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs | |
ATE86611T1 (en) | TOPICAL PHARMACEUTICALS FOR THE TREATMENT OF ACNE AND SKIN DISEASES. | |
IT1136624B (en) | COLIC ACID SALTIFICATION PRODUCTS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT INCLUDE THEM AS AN ACTIVE PRINCIPLE | |
DE68901172D1 (en) | (-) - 2-PYRAZOLINE COMPOUND, THEIR OPTICAL UNLOCKING AND THERAPEUTIC AGENT FOR THE TREATMENT OF CEREBRAL VEGETABLE DISEASES, CONTAINING THIS COMPOUND AS AN ACTIVE INGREDIENT. | |
Baluda et al. | The effects of administration of drugs influencing haemostasis during treatment of patients with burns | |
DE69126977D1 (en) | Use of leukoregulin for the treatment of animals infected with an envelope virus | |
Chiu | Rejuvenating effect of procaine: a critical review of reports | |
SU1221599A1 (en) | Method of determining pharmacological activity of preparation | |
SU659563A1 (en) | Aniline sulfosalicylate possessing antihelminthic activity |